TABLE 1.

Sera from pigs experimentally infected with various CSFV strains

SerumTime of testingaCSFV strain used
S#1 HC HyperImmune Serum P15-93 (302-08) 94-09-1515 dpc 4NA
S#2 HC HyperImmune Serum P16-93 94-09-2121 dpc 4NA
S#3 HC Antiserum P43-83 83-08-1617 dpc 5NA
S#4 HC Standard Serum P78-82 83-04-18166 dpiNA
S#5 HC P12-93 94-01-128 dpcAlfort
S#6 HC P17-93 93-12-2956 dpiGlentorf
S#7 HC P18-93 93-12-2956 dpiGlentorf
S#8 HC P19-93 93-12-3057 dpiGlentorf
S#9 HC P4-92 92-06-027 dpiGlentorf
S#10 HC P4-92 92-06-3035 dpiGlentorf
S#11 HC P5-92 92-06-027 dpiGlentorf
S#12 HC P5-92 92-06-0914 dpiGlentorf
S#13 HC P5-92 92-06-1621 dpiGlentorf
S#14 HC P5-92 92-06-3035 dpiGlentorf
S#15 HCV HyperImmune Serum P222 64-06-02NANA
S#16 HCV Antiserum L-1 P154 66-06-02210 dpiLapinized
S#17 HCV Antisera NT P155 66-06-22210 dpcLapinized
S#18 HCV Immune Sera 51PIC/41 P2427 P3C 69-01-1671 dpiNA
S#19 HCV Antiserum P54-83 83-10-24NAbNA
S#20 HC PA03 98-12-147 dpiAlfort
  • a Animals tested n dpc were infected with one CSFV strain followed by challenge with other CSFV strains during the course of infection.

  • b NA, not available.